Company Filing History:
Years Active: 2011
Title: Liching Cao: Innovator in Angiogenesis Detection
Introduction
Liching Cao is a notable inventor based in Vallejo, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of angiogenesis. His innovative work has the potential to impact the understanding and treatment of diseases associated with undesirable angiogenesis.
Latest Patents
Liching Cao holds a patent titled "Detection of activation of endothelial cells as surrogate marker for angiogenesis." This patent encompasses methods, compositions, and kits designed for the sensitive and direct detection of endothelial cell activation at molecular levels. The activation of endothelial cells is assessed by measuring the levels of cellular components and their protein complexes involved in specific angiogenesis signaling pathways. This method can be utilized to evaluate the status of diseases linked to undesirable angiogenesis, including the likelihood of disease development, presence or absence of the disease, prognosis, and response to anti-angiogenic therapies.
Career Highlights
Liching Cao is currently associated with Laboratory Corporation of America Holdings, where he applies his expertise in medical diagnostics. His work focuses on advancing methodologies that can guide the design of effective therapeutic regimens targeting specific angiogenic signaling pathways.
Collaborations
Some of Liching Cao's coworkers include Sean C Moore and Sharat Singh. Their collaborative efforts contribute to the innovative research and development in the field of angiogenesis detection.
Conclusion
Liching Cao's contributions to the detection of angiogenesis represent a significant advancement in medical diagnostics. His innovative patent and work at Laboratory Corporation of America Holdings highlight his commitment to improving disease assessment and treatment strategies.